FDA Approved: MACRILEN — Supplemental Application (Aeterna Zentaris GmbH)

View source ↗

Summary

The FDA is reviewing a supplemental application for MACRILEN (macimorelin acetate) by Aeterna Zentaris GmbH to update its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• MACRILEN (macimorelin acetate)

Snippet

SUPPL AP for MACRILEN (MACIMORELIN ACETATE)